Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +8.97% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.17 | N/A | +8.97% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management highlighted the positive EPS surprise as a sign of resilience. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
The company remains focused on long-term growth strategies.
Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell 6.1% in reaction, likely due to the lack of revenue information and future guidance. Investors may be cautious as they await more clarity on the company's performance outlook.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CROWN CASTLE INC REI REIT
Oct 21, 2013